New Biomarker Algorithm for Noninvasive Detection of Esophageal Cancer
A biomarker-based algorithm combined with a noninvasive test identifies those at risk for esophageal cancer or precancerous conditions.
Read MorePosted by Andy Lundin | Jan 22, 2025 | Unknown Origin & Other Cancer Types |
A biomarker-based algorithm combined with a noninvasive test identifies those at risk for esophageal cancer or precancerous conditions.
Read MorePosted by Andy Lundin | Jan 21, 2025 | Prostate |
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Read MorePosted by Andy Lundin | Jan 9, 2025 | Cancer, Molecular Diagnostics |
Summary: A Mayo Clinic-led international study utilized CRISPR-Cas9 technology to classify 91% of...
Read MorePosted by Andy Lundin | Dec 17, 2024 | Diagnostic Technologies |
Researchers have developed microchips that can identify multiple diseases from a single cough or air sample.
Read MorePosted by Andy Lundin | Dec 13, 2024 | Breast, Mass Spectrometry Instruments |
A new laser analysis and AI method capable of detecting stage 1a breast cancer with 98% accuracy offers an effective screening option.
Read More